Sign in

NCT02000089RecruitingPhase 3

The Cancer of the Pancreas Screening-5 CAPS5)Study

Source: ClinicalTrials.gov · Last updated 22 Oct 2026

Brief summary (registry, in English)

Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.

Status (registry)
Recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
9000 (estimated)
First submitted
26 Nov 2013
Start date
6 Jan 2014
Primary completion date
31 Dec 2028
Lead sponsor
Johns Hopkins University
NCT number
NCT02000089

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 9000
  • From 6 Jan 2014 to the primary completion date, 31 Dec 2028
  • 9 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior surgery that prevent optimal endoscopic ultrasound such as partial or complete gastrectomy with Bilroth or Roux-en-Y anastomosis

Other

  • Medical comorbidities or coagulopathy that contraindicate endoscopy
  • Stricture or obstruction in the upper GI tract that does not allow passage of the echoendoscope
  • Poor performance status
  • Inability to provide informed consent
  • Pregnancy.

Who the study is looking for

  • Hereditary Pancreatitis or
  • Peutz-Jeghers Syndrome or
  • Strong family history of pancreas cancer on one side of the family tree or
  • Confirmed germline mutation carrier (BRCA2, FAMMM (CDKN2A/p16), PALB2, BRCA1, ATM, HNPCC, Lynch Syndrome (hMLH1, hMSH2, PMS2, hMSH6, EpCAM) PRSS1, PRSS2, R122H, N291l, SPINK1, CFTR
  • Endoscopic evaluation of pancreas scheduled

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (9)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Michigan
Coordinator of this site? Confirm its status
Ann ArborUnited StatesRecruiting
Johns Hopkins Hospital
Coordinator of this site? Confirm its status
BaltimoreUnited StatesRecruiting
Dana Farber Cancer Center, Harvard University
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting
Case Comprehensive Cancer Center, Case Western Medical Reserve
Coordinator of this site? Confirm its status
ClevelandUnited StatesRecruiting
Yale University
Coordinator of this site? Confirm its status
New HavenUnited StatesRecruiting
Columbia University Medical Center
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting
NYU Langone Medical Center
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting
University of Pennsylvania
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting
University of Pittsburgh
Coordinator of this site? Confirm its status
PittsburghUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.